FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016000710> ?p ?o ?g. }

• W3016000710 endingPage "2680.e3" @default.
• W3016000710 startingPage "2673" @default.
• W3016000710 abstract "Greater severity in childhood asthma negatively impacts functioning and quality of life. Omalizumab is effective in children aged 6 years or older with moderate to severe persistent asthma, but predicting responsiveness in severe disease requires further study. To assess response to omalizumab treatment among children using indicators of asthma severity. Post hoc analyses of randomized placebo-controlled studies of omalizumab (Inner-City Anti-IgE Therapy for Asthma [ICATA], IA05, and Preventative Omalizumab or Step-up Therapy for Fall Exacerbations [PROSE]) stratified by body mass index, eosinophil count, fractional exhaled nitric oxide levels, and baseline severity indicators (baseline percent predicted FEV1, previous hospitalizations, asthma exacerbations). Poisson regression analysis examined exacerbation rate reductions for body mass index, biomarkers, and severity indicators. Children aged 6 to 11 years in IA05 (N = 576; 56% white, 17% black, 26% other/missing), ICATA (N = 237; 55% black, 43% Hispanic), and PROSE (N = 342; 59% black, 35% Hispanic) were included. Trends indicative of greater exacerbation rate change ([omalizumab – placebo]/placebo) were observed for low baseline lung function (IA05 percent predicted FEV1: <90%, 36% reduction, 95% CI, −53.3 to −13.5; ≥90%, 22% reduction, 95% CI, −52.1 to 27.5), previous hospitalizations (ICATA: 46% reduction with, 95% CI, −69.7 to −3.9; 24% reduction without, 95% CI, −48.1 to 10.3), frequent baseline exacerbations (IA05: ≥3, 42% reduction, 95% CI, −60.4 to −14.1; <3, 20% reduction, 95% CI, −45.2 to −15.9), and high baseline eosinophil count (IA05: ≥300 cells/μL, 39% reduction, 95% CI, −56.4 to −14.7; <300 cells/μL, 5% reduction, 95% CI, −40.6 to 52.1). Omalizumab reduces exacerbations in children with moderate to severe persistent allergic asthma, and may provide greater benefit in children with more severe asthma subtypes." @default.
• W3016000710 created "2020-04-17" @default.
• W3016000710 creator A5006031044 @default.
• W3016000710 creator A5025601511 @default.
• W3016000710 creator A5033765434 @default.
• W3016000710 creator A5044980958 @default.
• W3016000710 creator A5053044434 @default.
• W3016000710 creator A5063391135 @default.
• W3016000710 creator A5069959810 @default.
• W3016000710 date "2020-09-01" @default.
• W3016000710 modified "2023-09-27" @default.
• W3016000710 title "Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity" @default.
• W3016000710 cites W185032862 @default.
• W3016000710 cites W1876031798 @default.
• W3016000710 cites W1895107 @default.
• W3016000710 cites W1965484089 @default.
• W3016000710 cites W1983832849 @default.
• W3016000710 cites W1985643930 @default.
• W3016000710 cites W1988096894 @default.
• W3016000710 cites W1999291709 @default.
• W3016000710 cites W2020989669 @default.
• W3016000710 cites W2038409356 @default.
• W3016000710 cites W2049160101 @default.
• W3016000710 cites W2050878314 @default.
• W3016000710 cites W2064260812 @default.
• W3016000710 cites W2065420773 @default.
• W3016000710 cites W2066719939 @default.
• W3016000710 cites W2086746792 @default.
• W3016000710 cites W2104537618 @default.
• W3016000710 cites W2112468123 @default.
• W3016000710 cites W2121739711 @default.
• W3016000710 cites W2121954044 @default.
• W3016000710 cites W2123669151 @default.
• W3016000710 cites W2137373998 @default.
• W3016000710 cites W2143512911 @default.
• W3016000710 cites W2146852572 @default.
• W3016000710 cites W2153384298 @default.
• W3016000710 cites W2161956191 @default.
• W3016000710 cites W2171974734 @default.
• W3016000710 cites W2357940608 @default.
• W3016000710 cites W2521435480 @default.
• W3016000710 cites W2521657843 @default.
• W3016000710 cites W2573857289 @default.
• W3016000710 cites W2581649500 @default.
• W3016000710 cites W2587482926 @default.
• W3016000710 cites W2600807553 @default.
• W3016000710 cites W2601675613 @default.
• W3016000710 cites W2606779794 @default.
• W3016000710 cites W2610654869 @default.
• W3016000710 cites W2750584686 @default.
• W3016000710 cites W2759311632 @default.
• W3016000710 cites W2782835876 @default.
• W3016000710 cites W2788940507 @default.
• W3016000710 cites W2791719145 @default.
• W3016000710 cites W2791933168 @default.
• W3016000710 cites W2803941918 @default.
• W3016000710 cites W2891529252 @default.
• W3016000710 doi "https://doi.org/10.1016/j.jaip.2020.03.033" @default.
• W3016000710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32298853" @default.
• W3016000710 hasPublicationYear "2020" @default.
• W3016000710 type Work @default.
• W3016000710 sameAs 3016000710 @default.
• W3016000710 citedByCount "9" @default.
• W3016000710 countsByYear W30160007102020 @default.
• W3016000710 countsByYear W30160007102021 @default.
• W3016000710 countsByYear W30160007102022 @default.
• W3016000710 countsByYear W30160007102023 @default.
• W3016000710 crossrefType "journal-article" @default.
• W3016000710 hasAuthorship W3016000710A5006031044 @default.
• W3016000710 hasAuthorship W3016000710A5025601511 @default.
• W3016000710 hasAuthorship W3016000710A5033765434 @default.
• W3016000710 hasAuthorship W3016000710A5044980958 @default.
• W3016000710 hasAuthorship W3016000710A5053044434 @default.
• W3016000710 hasAuthorship W3016000710A5063391135 @default.
• W3016000710 hasAuthorship W3016000710A5069959810 @default.
• W3016000710 hasBestOaLocation W30160007101 @default.
• W3016000710 hasConcept C126322002 @default.
• W3016000710 hasConcept C141105273 @default.
• W3016000710 hasConcept C142724271 @default.
• W3016000710 hasConcept C159654299 @default.
• W3016000710 hasConcept C187212893 @default.
• W3016000710 hasConcept C203014093 @default.
• W3016000710 hasConcept C204787440 @default.
• W3016000710 hasConcept C27081682 @default.
• W3016000710 hasConcept C2776042228 @default.
• W3016000710 hasConcept C2777014857 @default.
• W3016000710 hasConcept C2777037409 @default.
• W3016000710 hasConcept C2778564945 @default.
• W3016000710 hasConcept C2780221984 @default.
• W3016000710 hasConcept C2780769369 @default.
• W3016000710 hasConcept C2781142857 @default.
• W3016000710 hasConcept C2908647359 @default.
• W3016000710 hasConcept C71924100 @default.
• W3016000710 hasConcept C73269764 @default.
• W3016000710 hasConcept C99454951 @default.
• W3016000710 hasConceptScore W3016000710C126322002 @default.
• W3016000710 hasConceptScore W3016000710C141105273 @default.
• W3016000710 hasConceptScore W3016000710C142724271 @default.

• next